Literature DB >> 19476540

Gene expression profiling to define host response to baculoviral transduction in the brain.

Jérôme Boulaire1, Ying Zhao, Shu Wang.   

Abstract

Recombinant baculoviral vectors efficiently transduce several types of cells in the brain. To characterize host responses to virus challenge, thus verifying the suitability of using baculovirus for the development of gene therapy strategies in the central nervous system, we used cDNA microarray technology to examine in vitro and in vivo global cellular gene expression profiles in the rat brain, cultured human astrocytes and human neuronal cells after viral transduction. We demonstrated that the transduction induced host antiviral responses as a major reaction in all three types of samples profiled. The related genes were mainly those associated with innate immunity, including several of the genes involved in Toll-like receptor signaling pathway and cytokine-cytokine receptor interaction. These findings should be useful in understanding the molecular basis for neural cell response to baculoviral transduction and in guiding rational therapeutic applications of baculoviral vectors in the central nervous systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19476540     DOI: 10.1111/j.1471-4159.2009.06015.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells.

Authors:  Chikako Ono; Akinori Ninomiya; Satomi Yamamoto; Takayuki Abe; Xiauyu Wen; Takasuke Fukuhara; Miwa Sasai; Masahiro Yamamoto; Tatsuya Saitoh; Takashi Satoh; Taro Kawai; Ken J Ishii; Shizuo Akira; Toru Okamoto; Yoshiharu Matsuura
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

2.  Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction.

Authors:  Guan-Yu Chen; Shiaw-Min Hwang; Hung-Ju Su; Chien-Yi Kuo; Wen-Yi Luo; Kai-Wei Lo; Cheng-Chieh Huang; Chiu-Ling Chen; Sheng-Han Yu; Yu-Chen Hu
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 3.  Gene regulation and genetics in neurochemistry, past to future.

Authors:  Steven W Barger
Journal:  J Neurochem       Date:  2016-10-17       Impact factor: 5.372

4.  Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma.

Authors:  Suzanne M Birks; John Owusu Danquah; Linda King; Reinhardt Vlasak; Dariusz C Gorecki; Geoffrey J Pilkington
Journal:  Neuro Oncol       Date:  2011-07-31       Impact factor: 12.300

Review 5.  Recognition of virus infection and innate host responses to viral gene therapy vectors.

Authors:  Dmitry M Shayakhmetov; Nelson C Di Paolo; Karen L Mossman
Journal:  Mol Ther       Date:  2010-06-15       Impact factor: 11.454

6.  Bone Marrow Mesenchymal Stem Cells Expressing Baculovirus-Engineered Bone Morphogenetic Protein-7 Enhance Rabbit Posterolateral Fusion.

Authors:  Jen-Chung Liao
Journal:  Int J Mol Sci       Date:  2016-07-05       Impact factor: 5.923

Review 7.  Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications.

Authors:  Chi-Yuan Chen; Chin-Yu Lin; Guan-Yu Chen; Yu-Chen Hu
Journal:  Biotechnol Adv       Date:  2011-04-28       Impact factor: 14.227

8.  Characterization of the Gene Expression Patterns in the Murine Liver Following Intramuscular Administration of Baculovirus.

Authors:  Mitsuhiro Iyori; Ryohei Ogawa; Talha Bin Emran; Shuta Tanbo; Shigeto Yoshida
Journal:  Gene Expr       Date:  2020-10-28

Review 9.  Baculovirus-mediated gene delivery and RNAi applications.

Authors:  Kaisa-Emilia Makkonen; Kari Airenne; Seppo Ylä-Herttulala
Journal:  Viruses       Date:  2015-04-22       Impact factor: 5.048

10.  Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors.

Authors:  Nicolas Merienne; Juliette Le Douce; Emilie Faivre; Nicole Déglon; Gilles Bonvento
Journal:  Front Cell Neurosci       Date:  2013-07-05       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.